Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycaemia.

CONCLUSIONS: The analysis shows that treating people with type 1 diabetes who are prone to recurrent severe hypoglycaemia with an insulin analogue regimen is cost-effective compared with a human insulin regimen. PMID: 27326862 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27326862?dopt=Abstract

Source: Current Medical Research and Opinion - June 23, 2016 Category: Research Tags: Curr Med Res Opin Source Type: research